USP8 and hepatocellular carcinoma: Inhibition of USP8, by stabilizing OGT and impacting cystine uptake via SLC7A11, effectively suppresses hepatocellular carcinoma progression and induces ferroptosis, suggesting its potential as a therapeutic target for HCC treatment.